Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of two intravenous agents. **Ringer’s lactate** (also known as lactated Ringer’s solution) is a balanced crystalloid fluid used for intravenous hydration and electrolyte replacement. **Ciprofloxacin** is a fluoroquinolone antibiotic that kills bacteria by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby disrupting DNA replication and repair[6][8][10]. The combination itself is not an approved or marketed product but may be encountered in clinical practice when both agents are administered via the same IV line or Y-site. However, these drugs are physically incompatible when mixed together due to precipitation risk[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ringer's lactate + ciprofloxacin.